CareDx (NASDAQ: CDNA) CFO & COO granted 24,134 RSUs in equity award

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Kennedy Keith reported acquisition or exercise transactions in this Form 4 filing.

CareDx, Inc. CFO & COO Keith Kennedy received a grant of 24,134 shares of Common Stock in the form of restricted stock units at a price of $0.00 per share. After this award, he directly holds 221,548 shares.

According to the terms, one-third of these RSUs will vest on April 6, 2027. The remaining two-thirds will vest in equal quarterly installments over the next eight quarters, so that all units vest by the third anniversary of April 6, 2027, if his employment continues through each vesting date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kennedy Keith

Role CFO & COO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	24,134	$0.00	--

Holdings After Transaction: Common Stock — 221,548 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 24,134 shares Grant price: $0.00/share Post-transaction holdings: 221,548 shares +2 more

5 metrics

RSU grant size 24,134 shares Restricted stock units granted on April 20, 2026

Grant price $0.00/share RSU award to CFO & COO Keith Kennedy

Post-transaction holdings 221,548 shares Total Common Stock directly held after RSU grant

Initial vesting date April 6, 2027 One-third of RSUs vest on this date

Final vesting timeline Third anniversary of April 6, 2027 All RSUs vested by this date if employment continues

Key Terms

restricted stock units, RSUs, vesting, quarterly installments

4 terms

restricted stock units financial

"The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

vesting financial

"one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

quarterly installments financial

"the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each"

Form 4 Insider Transactions: What Each Field Means →

04/22/2026 - 04:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kennedy Keith

(Last)

(First)

(Middle)

C/O CAREDX, INC.

8000 MARINA BLVD, 4TH FLOOR

(Street)

BRISBANE

CALIFORNIA

94005

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CFO & COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/20/2026		A		24,134⁽¹⁾	A	$0	221,548	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the RSUs will be vested on the third anniversary of April 6, 2027, subject to the Reporting Person's continuous employment on each applicable vesting date.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	04/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did CareDx (CDNA) report for Keith Kennedy?

CareDx reported that CFO & COO Keith Kennedy received a grant of 24,134 restricted stock units of Common Stock at $0.00 per share. This is a compensation-related award, not an open-market purchase, increasing his direct equity stake in the company.

How many CareDx (CDNA) shares does Keith Kennedy hold after this Form 4?

Following the reported grant, Keith Kennedy directly holds 221,548 shares of CareDx Common Stock. This total includes the newly granted 24,134 restricted stock units, which will vest over time according to the specified schedule tied to his continued employment.

What is the vesting schedule for Keith Kennedy’s 24,134 CareDx RSUs?

One-third of the 24,134 RSUs will vest on April 6, 2027. The remaining two-thirds will vest in equal quarterly installments over the following eight quarters, so all units vest by the third anniversary of April 6, 2027, subject to his continuous employment.

Is Keith Kennedy’s CareDx Form 4 transaction an open-market stock purchase?

No. The transaction reflects a grant of 24,134 restricted stock units as compensation, recorded at $0.00 per share. It is categorized as a grant or award acquisition, not an open-market buy or sell, and vests over multiple future dates.

What role does Keith Kennedy hold at CareDx (CDNA) in this Form 4?

In the Form 4, Keith Kennedy is identified as an officer of CareDx serving as CFO & COO. The reported transaction shows a direct ownership award of restricted stock units that align his compensation more closely with CareDx’s long-term share performance.